Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II

Immunity

Volumn 14, Issue 1, 2001, Pages 93-104

  Li, Yili ^a   Li, Hongmin ^a   Dimasi, Nazzareno ^a   McCormick, John K ^b   Martin, Roland ^c   Schuck, Peter ^d   Schlievert, Patrick M ^b   Mariuzza, Roy A ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; HLA DR2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN BASIC PROTEIN; PEPTIDE HORMONE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; ZINC;

ALPHA CHAIN; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BETA CHAIN; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS;

EID: 0035129453     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00092-9     Document Type: Article

References (68)

1. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A
2. Analysis of zinc binding sites in protein crystals
3. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
4. Small amounts of superantigen, when presented by dendritic cells, are sufficient to initiate T cell responses
5. Staphylococcal enterotoxins B and C: structural requirements for superantigenic and entertoxigenic activities
6. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses
7. Crystallography & NMR System: A new software suite for macromolecular structure determination
8. Staphylococcal toxins bind to different sites on HLA-DR
9. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s
10. Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease
11. The CCP4 suite: Programs for protein crystallography
12. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes
13. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
14. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II
15. Exotoxins of Staphylococcus aureus
16. A full genome search in multiple sclerosis
17. Empty and peptide-loaded class II MHC proteins produced by expression in E. coli and refolding in vitro
18. Structures of an MHC class II molecule with covalently bound single peptides
19. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme
20. Structural basis of T cell recognition
21. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
22. Identification of the staphylococcal enterotoxin A superantigen binding site in the β1 domain of the human histocompatibility antigen HLA-DR
23. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families
24. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II
25. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
26. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1
27. Superantigens of Gram-positive bacteria: Structure-function analyses and their implications for biological activity
28. Superantigens and their potential role in human disease
29. Multiple binding sites for bacterial superantigens on soluble class II molecules
30. PROCHECK: A program to check the stereochemical quality of protein structures
31. Computer-aided interpretation of analytical sedimentation data for proteins
32. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM
33. Shape complementarity at protein-protein interfaces
34. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
35. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
36. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action
37. The structural basis of T cell activation by superantigens
38. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins
39. The atomic structure of protein-protein recognition sites
40. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome
41. Toxins and superantigens of group A Streptococci
42. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A is a requirement for inflammatory cytokine gene expression
43. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: Implications for the structural basis of the specificity of peptide binding
44. AMoRe: An automated package for molecular replacement
45. Genetics of demyelinating diseases
46. Processing X-ray diffraction data collected in oscillation mode
47. Superantigens as immunomodulators: Recent structural insights
48. The crystal structure of a T cell receptor in complex with peptide and MHC class II
49. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand
50. TURBO-FRODO
51. Crystal structure of the streptococcal superantigen SPE-C: Dimerization and zinc-binding suggest a novel mode of interaction with MHC class II molecules
52. Crystal structure of the superantigen staphylococcal enterotoxin type A
53. Superantigens: Bacterial and viral proteins that manipulate the immune system
54. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules
55. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues
56. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein
57. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
58. Luxury accomodations: The expanding role of structural plasticity in protein-protein interactions
59. Antigen-induced suppression of the proliferative response of T cell clones
60. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding
61. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation
62. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides
63. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells
64. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells
65. Why do superantigens care about peptides?
66. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins